![David Anderson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Anderson
Director/Miembro de la Junta en Halsa Pharmaceuticals, Inc. .
Perfil
David Anderson is currently a Director at Halsa Pharmaceuticals, Inc. He was previously the Chairman, President & Chief Executive Officer at MithraGen, Inc. from 2001 to 2009, Chairman at PLx Pharma, Inc., Chairman at Nanospectra Biosciences, Inc., and Chief Operating Officer at Tanox, Inc. from 1987 to 2013.
Mr. Anderson received a graduate degree from the University of Houston in 1976 and an undergraduate degree from the same institution.
Cargos activos de David Anderson
Empresas | Cargo | Inicio |
---|---|---|
Halsa Pharmaceuticals, Inc. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de David Anderson.
Empresas | Cargo | Fin |
---|---|---|
MithraGen, Inc.
![]() MithraGen, Inc. Pharmaceuticals: MajorHealth Technology MithraGen, Inc. develops immunotherapies for the treatment and prevention of cancer and infectious diseases. The company was founded in 2000 and is headquartered in Houston, TX. | Presidente | 01/01/2009 |
PLx Pharma, Inc. /Old/
![]() PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX. | Presidente | 24/08/2011 |
Tanox, Inc.
![]() Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Director de Operaciones | - |
Nanospectra Biosciences, Inc.
![]() Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Presidente | - |
Formación de David Anderson.
University of Houston | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 5 |
---|---|
Tanox, Inc.
![]() Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
PLx Pharma, Inc. /Old/
![]() PLx Pharma, Inc. /Old/ Pharmaceuticals: OtherHealth Technology PLx Pharma, Inc. engages in the development of formulations of non steroidal anti-inflammatory drugs. Its products include GI-safer NSAID technology and product pipeline; aspirin, ibuprofen and indomethacin as well as other drugs for over-the-counter and prescription markets using the PLxGuard technology. The company was founded in 2003 and is headquartered in Houston, TX. | Health Technology |
Nanospectra Biosciences, Inc.
![]() Nanospectra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Nanospectra Biosciences, Inc. provides commercializing particle-based therapies the selective and precise thermal destruction of solid tumors. It develops AuroLase Therapy utilizing AuroShell Particles (also referred to as nanoshells) for the precise, particle-based thermal ablation of solid tumors. The company was founded by Naomi J. Halas, Jennifer L. West, and Daniel M. Watkins in 2002 and is headquartered in Houston, TX. | Health Technology |
MithraGen, Inc.
![]() MithraGen, Inc. Pharmaceuticals: MajorHealth Technology MithraGen, Inc. develops immunotherapies for the treatment and prevention of cancer and infectious diseases. The company was founded in 2000 and is headquartered in Houston, TX. | Health Technology |
Halsa Pharmaceuticals, Inc. |
- Bolsa de valores
- Insiders
- David Anderson